Find and Pitch Jounalists, Get Your Story Covered

Tags: cancer metformin myeloid leukemia burn scars marjolin's ulcer

	Profile	Recent Articles on Subject
1	David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK Technologysciencewriting	Lung Cancer Is Rising in Non-Smokers, And This Could Be Why - 17 days ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Amgen’s lung cancer treatment gets conditional approval - about 2 months ago EC approves Rybrevant with Lazcluze for advanced lung cancer - 2 months ago Imfinzi receives NICE recommendation for lung cancer treatment - 3 months ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	New First-Line Option for Advanced ALK-Positive Lung Cancer - 3 months ago Trial Questions Role of Dual Immunotherapy in First-Line NSCLC - 6 months ago Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - 7 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 8 months ago First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests - 12 months ago Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC - about 1 year ago Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug - about 1 year ago Pembrolizumab Wins FDA Approval in Operable Lung Cancer - over 1 year ago Can ctDNA Guide Radiation Use in Oligometastatic NSCLC? - over 1 year ago
4	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	New Strategies in SCLC and DLBCL Are Transforming the Treatment Landscape - 3 months ago CHMP Recommends Lazertinib With Amivantamab to Treat EGFR-Mutated Advanced NSCLC - 4 months ago Researchers Find Lack of Communication for Lung Cancer Screenings Among High-Risk Individuals - 4 months ago Lung Cancer Screenings Can Save Lives, Yet Uptake Remains Low - 4 months ago Treatment Considerations for Patients With Small Cell Lung Cancer, Pre-Existing Interstitial Lung Disease - 6 months ago Advances With Various Therapies Targeting DLL3 in Lung Neuroendocrine Tumors - 6 months ago FDA Grants Priority Review for Durvalumab to Treat Small Cell Lung Cancer - 7 months ago Novel Chemotherapy Method Could Decrease Lung Cancer Tumor Size - about 1 year ago Researchers Highlight Need for Additional Research in Advanced Non–Small Cell Lung Cancer - about 1 year ago Researchers Assess Second Primary Lung Cancer Among Survivors Without Smoking History - about 1 year ago Researchers Publish Recommendations on Low-Dose Computed Tomography Screenings for Lung Cancer - about 1 year ago Study: Researchers Find Benefits in Lung Nodule Program to Aid Lung Cancer Diagnosis - about 1 year ago Researchers Find Allergy Medication Could Aid Treatment for Lung Cancer - about 1 year ago
5	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 6 months ago
6	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study - 6 months ago STAT+: Lung cancer drug from iTeos, GSK shows response, boosting TIGIT as a viable target - 6 months ago STAT+: Roche drug slashes recurrence, death risk in lung cancer that afflicts younger patients - over 1 year ago STAT+: Study on Amgen’s ‘bispecific’ immunotherapy could lead to approval in small cell lung cancer - over 1 year ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Expert Discusses Immunotherapy, Antibody Drug Conjugates for Lung Cancer - 6 months ago Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC - 6 months ago Local Therapy Developments Hold Promise for Survival Improvements for NSCLC - 6 months ago FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - 7 months ago FDA Grants Breakthrough Therapy Designation to NVL-520 for ROS1-Positive NSCLC - about 1 year ago FDA Approves Osimertinib With Chemotherapy for EGFRm NSCLC - about 1 year ago Pharmacists May See Patients With NSCLC More Often Than Other Care Team Members - about 1 year ago
8	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA Expands Durvalumab Label to Operable Lung Cancer - 7 months ago FDA OKs Amivantamab as First-Line Lung Cancer Treatment - 12 months ago New Options Challenge Standard Treatments in EGFR-Mutant NSCLC - over 1 year ago
9	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 8 months ago Novel TKI Promising in Early Study of HER2-Mutant NSCLC - 8 months ago The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer - over 1 year ago What's New in Targeted Lung Cancer Treatment? - over 1 year ago
10	The Conversation Science Alert Science news. Official account. Australia science news	Tiny Algae Microrobots Could Transform Lung Cancer Treatment - 9 months ago

Journalists covering non-small cell lung cancer